通过合理设计的主导阴性TNF变体来非激活TNF信号传递
Paul M Steed1, Malú G Tansey, Jonathan Zalevsky
1Xencor, 111 West Lemon Avenue, Monrovia, CA 91016, USA.
概括
科学家们设计了变异性瘤亡因子 (TNF) 蛋白质,以中和原生TNF. 这种策略通过隔离来禁用TNF,为抗炎生物治疗药物提供了潜在的新方法.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
背景情况:
- 瘤亡因子 (TNF) 是炎症的关键调节者.
- 失调的TNF信号与许多病理状况有关.
- 向TNF是治疗炎症疾病的关键策略.
研究的目的:
- 为了设计能够抑制本源TNF活性的变异性TNF蛋白质.
- 通过蛋白质复合体的形成来开发一种新的策略来禁用TNF.
- 探索主导阴性TNF变体作为抗炎生物治疗药物的潜力.
主要方法:
- 基于结构的蛋白质设计被用来设计新的TNF变体.
- 工程变体的设计是为了形成与本地TNF的异构分离体.
- 评估了这些异构体对TNF受体结合和信号传递的功能后果.
主要成果:
- 工程TNF变体迅速与本地TNF形成异构三元复合体.
- 这些复杂物有效地隔离本地TNF,防止受体结合.
- 该策略在动物模型中证明了TNF介导病理的减弱.
- 改造的主导阴性TNFs显示出作为抗炎药物的潜力.
结论:
- 主导阴性TNF变体可以合理设计以抑制TNF功能.
- 通过封存的TNF无活化为炎症状况提供了一个可行的治疗策略.
- 这种方法可能可以扩展到TNF超级家族内的其他多重细胞因子.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...


